🔗 Permalink

Inventor profile of:

Thomas E. Hughes

City:

Boston, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2019-07-25

Top Assignees for applications by Thomas E. Hughes

The entities that hold a legal rights for patent applications filed by inventor Hughes Thomas E.:

ZAFGEN, INC. 12 Boston, MA United States
Zafgen Inc. 6 Cambridge, MA United States
VANDERBILT UNIVERSITY 2 Nashville, TN United States

Recent patent applications by Hughes Thomas E.

Thomas E. Hughes from Boston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-07-25

US20190224156A1

Human necessities

Methods of Treating an Overweight or Obese Subject

#2 | 2019-06-13

US20190175542A1

Human necessities

METHODS OF TREATING AGE RELATED DISORDERS

#3 | 2018-08-09

US20180221328A1

Human necessities

Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol

#4 | 2018-03-29

US20180085338A1

Human necessities

Methods of treating ischemic organ damage and other disorders

#5 | 2018-03-08

US20180064677A1

Human necessities

Methods of Treating an Overweight or Obese Subject

#6 | 2018-03-01

US20180055811A1

Human necessities

Methods of treating an overweight subject

#7 | 2018-02-15

US20180042886A1

Human necessities

METHODS OF TREATING AGE RELATED DISORDERS

#8 | 2017-11-23

US20170333383A1

Human necessities

Methods of treating impaired wound healing

#9 | 2017-11-16

US20170326099A1

Human necessities

Methods of treating liver diseases

#10 | 2017-07-13

US20170196829A1

Human necessities

METHODS OF TREATING AGE RELATED DISORDERS

#11 | 2016-08-25

US20160243073A1

Human necessities

Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol

#12 | 2016-06-16

US20160166531A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISORDERS

#13 | 2016-03-03

US20160058731A1

Human necessities

Methods of treating liver diseases

#14 | 2016-02-11

US20160038453A1

Human necessities

Methods of treating renal disease and other disorders

#15 | 2015-11-26

US20150335608A1

Human necessities

Methods of treating an overweight subject

#16 | 2015-07-30

US20150209321A1

Human necessities

TREATMENT OF OBESITY USING NON-DAILY ADMINISTRATION OF 6-O-(4-DIMETHYLAMINOETHOXY) CINNAMOYL FUMAGILLOL

#17 | 2015-07-30

US20150209320A1

Human necessities

METHODS OF TREATING AN OVERWEIGHT OR OBESE SUBJECT

#18 | 2014-11-13

US20140336251A1

Human necessities

Methods of treating age related disorders

#19 | 2014-03-13

US20140073691A1

Human necessities

Methods and composition for Treating Thyroid Hormone Related Disorders

#20 | 2014-02-20

US20140051752A1

Human necessities

Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol

#21 | 2014-02-13

US20140045935A1

Human necessities

Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol

#22 | 2014-02-13

US20140045934A1

Human necessities

Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol

#23 | 2014-01-09

US20140011870A1

Human necessities

Methods of Treating Obesity Using an Effective Dose of a METAP-2 Inhibitor

#24 | 2013-11-28

US20130316994A1

Human necessities

Methods of Reducing Risk of Hepatobiliary Dysfunction During Rapid Weight Loss with METAP-2 Inhibitors

InventorID:

548991 ⎘